Evidence map›Paper›PMID 31186419›Full record

ArticleCell death & disease2019

Sonodynamic therapy inhibits palmitate-induced beta cell dysfunction via PINK1/Parkin-dependent mitophagy.

Tian Guo, Tianyang Liu, Yun Sun, Xianna Liu, Rongguo Xiong, He Li, Zhitao Li, Zhiguo Zhang, Zhen Tian, Ye Tian

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Mitochondria-associated programmed cell death in pancreatic β cell of T2DM.Apoptosis : an international journal on programmed cell death · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. The Role of Oxidative Stress in Pancreatic β Cell Dysfunction in Diabetes.International journal of molecular sciences · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. New Insights for nicotinamide: Metabolic disease, autophagy, and mTOR.Frontiers in bioscience (Landmark edition) · 2020
    Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tian GuoDepartment of Pathophysiology, Harbin Medical University, Harbin, 150081, China.
Tianyang LiuDepartment of Pathophysiology, Harbin Medical University, Harbin, 150081, China.
Yun SunDepartment of Pathophysiology, Harbin Medical University, Harbin, 150081, China.
Xianna LiuDepartment of Pathophysiology, Harbin Medical University, Harbin, 150081, China.
Rongguo XiongDepartment of Pathophysiology, Harbin Medical University, Harbin, 150081, China.
He LiDepartment of Pathophysiology, Harbin Medical University, Harbin, 150081, China.
Zhitao LiDepartment of Pathophysiology, Harbin Medical University, Harbin, 150081, China.
Zhiguo ZhangLaboratory of Photo- and Sono-theranostic Technologies and Condensed Matter Science and Technology Institute, Harbin Institute of Technology, Harbin, 150001, China.
Zhen TianDepartment of Pathophysiology, Harbin Medical University, Harbin, 150081, China. tianzhen@hrbmu.edu.cn.ORCID http://orcid.org/0000-0001-9044-637X
Ye TianDepartment of Pathophysiology, Harbin Medical University, Harbin, 150081, China. yetian@ems.hrbmu.edu.cn.
Harbin Medical University · CNHarbin Institute of Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In type 2 diabetes mellitus (T2DM), the overload of glucose and lipids can promote oxidative stress and inflammatory responses and contribute to the failure of beta cells. However, therapies that can modulate the function of beta cells and thus prevent their failure have not been well explored. In this study, beta cell injury model was established with palmitic acid (PA) to simulate the lipotoxicity (high-fat diet) found in T2DM. Sonodynamic therapy (SDT), a novel physicochemical treatment, was applied to treat injured beta cells. We found that SDT had specific effects on mitochondria and induced transient large amount of mitochondrial reactive oxygen species (ROS) production in beta cells. SDT also improved the morphology and function of abnormal mitochondria, inhibited inflammatory response and reduced beta cell dysfunction. The improvement of mitochondria was mediated by PINK1/Parkin-dependent mitophagy. Additionally, SDT rescued the transcription of PINK1 mRNA which was blocked by PA treatment, thus providing abundant PINK1 for mitophagy. Moreover, SDT also increased insulin secretion from beta cells. The protective effects of SDT were abrogated when mitophagy was inhibited by cyclosporin A (CsA). In summary, SDT potently inhibits lipotoxicity-induced beta cell failure via PINK1/Parkin-dependent mitophagy, providing theoretical guidance for T2DM treatment in aspects of islet protection.

Indexed as

Ultrasonic WavesAnimalsCarrier ProteinsCell LineCell SurvivalDiabetes Mellitus, Type 2InflammationInsulin-Secreting CellsMitochondriaMitophagyPalmitic AcidProtein KinasesProtoporphyrinsPTEN-Induced Putative KinaseRatsReactive Oxygen SpeciesCarrier ProteinsPalmitic Acidparkin proteinProtein Kinasesprotoporphyrin IXProtoporphyrinsPTEN-Induced Putative KinaseReactive Oxygen SpeciesReceptors, GABA-ATspo protein, ratUbiquitin-Protein Ligases

Identifiers

PMID31186419
PMCPMC6560035
OpenAlexW2950875560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.